SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-21-106404
Filing Date
2021-08-16
Accepted
2021-08-16 16:47:29
Documents
51
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tmb-20210630x10q.htm   iXBRL 10-Q 1086953
2 EXHIBIT 31.1 tmb-20210630xex31d1.htm EX-31.1 14929
3 EXHIBIT 32.1 tmb-20210630xex32d1.htm EX-32.1 7960
  Complete submission text file 0001104659-21-106404.txt   4382368

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA tmb-20210630.xsd EX-101.SCH 32496
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tmb-20210630_cal.xml EX-101.CAL 39039
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tmb-20210630_def.xml EX-101.DEF 95870
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE tmb-20210630_lab.xml EX-101.LAB 264117
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tmb-20210630_pre.xml EX-101.PRE 217263
9 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20210630x10q_htm.xml XML 754544
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 6502444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

IRS No.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-13341 | Film No.: 211179249
SIC: 2836 Biological Products, (No Diagnostic Substances)